27 related articles for article (PubMed ID: 19010928)
1. Small-molecule IKKβ activation modulator (IKAM) targets MAP3K1 and inhibits pancreatic tumor growth.
Napoleon JV; Sagar S; Kubica SP; Boghean L; Kour S; King HM; Sonawane YA; Crawford AJ; Gautam N; Kizhake S; Bialk PA; Kmiec E; Mallareddy JR; Patil PP; Rana S; Singh S; Prahlad J; Grandgenett PM; Borgstahl GEO; Ghosal G; Alnouti Y; Hollingsworth MA; Radhakrishnan P; Natarajan A
Proc Natl Acad Sci U S A; 2022 May; 119(18):e2115071119. PubMed ID: 35476515
[TBL] [Abstract][Full Text] [Related]
2. Chromatinized protein kinase C-θ directly regulates inducible genes in epithelial to mesenchymal transition and breast cancer stem cells.
Zafar A; Wu F; Hardy K; Li J; Tu WJ; McCuaig R; Harris J; Khanna KK; Attema J; Gregory PA; Goodall GJ; Harrington K; Dahlstrom JE; Boulding T; Madden R; Tan A; Milburn PJ; Rao S
Mol Cell Biol; 2014 Aug; 34(16):2961-80. PubMed ID: 24891615
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a novel curcumin analog P1 as potent inhibitor of the NF-κB signaling pathway with distinct mechanisms.
Peng YM; Zheng JB; Zhou YB; Li J
Acta Pharmacol Sin; 2013 Jul; 34(7):939-50. PubMed ID: 23603982
[TBL] [Abstract][Full Text] [Related]
4. The landscape of host transcriptional response programs commonly perturbed by bacterial pathogens: towards host-oriented broad-spectrum drug targets.
Kidane YH; Lawrence C; Murali TM
PLoS One; 2013; 8(3):e58553. PubMed ID: 23516507
[TBL] [Abstract][Full Text] [Related]
5. Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment.
Li X; Ma Q; Xu Q; Duan W; Lei J; Wu E
Curr Pharm Des; 2012; 18(17):2404-15. PubMed ID: 22372501
[TBL] [Abstract][Full Text] [Related]
6. The transcription factor Erg controls endothelial cell quiescence by repressing activity of nuclear factor (NF)-κB p65.
Dryden NH; Sperone A; Martin-Almedina S; Hannah RL; Birdsey GM; Khan ST; Layhadi JA; Mason JC; Haskard DO; Göttgens B; Randi AM
J Biol Chem; 2012 Apr; 287(15):12331-42. PubMed ID: 22337883
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a novel IKK-β inhibitor by ligand-based virtual screening techniques.
Noha SM; Atanasov AG; Schuster D; Markt P; Fakhrudin N; Heiss EH; Schrammel O; Rollinger JM; Stuppner H; Dirsch VM; Wolber G
Bioorg Med Chem Lett; 2011 Jan; 21(1):577-83. PubMed ID: 21078555
[TBL] [Abstract][Full Text] [Related]
8. Maslinic acid potentiates the anti-tumor activity of tumor necrosis factor alpha by inhibiting NF-kappaB signaling pathway.
Li C; Yang Z; Zhai C; Qiu W; Li D; Yi Z; Wang L; Tang J; Qian M; Luo J; Liu M
Mol Cancer; 2010 Apr; 9():73. PubMed ID: 20367887
[TBL] [Abstract][Full Text] [Related]
9. 3,3'-Diindolylmethane enhances chemosensitivity of multiple chemotherapeutic agents in pancreatic cancer.
Banerjee S; Wang Z; Kong D; Sarkar FH
Cancer Res; 2009 Jul; 69(13):5592-600. PubMed ID: 19531648
[TBL] [Abstract][Full Text] [Related]
10. IKK{beta} as a target for treatment of inflammation induced bone loss.
Ruocco MG; Karin M
Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv81-5. PubMed ID: 16239395
[TBL] [Abstract][Full Text] [Related]
11. Identification of a thienopyrimidine derivatives target by a kinome and chemical biology approach.
Lee C; Yang JS; Han G
Arch Pharm Res; 2015 Sep; 38(9):1575-81. PubMed ID: 26186885
[TBL] [Abstract][Full Text] [Related]
12. IkappaBalpha kinase inhibitor IKI-1 conferred tumor necrosis factor alpha sensitivity to pancreatic cancer cells and a xenograft tumor model.
Zhang Y; Gavriil M; Lucas J; Mandiyan S; Follettie M; Diesl V; Sum FW; Powell D; Haney S; Abraham R; Arndt K
Cancer Res; 2008 Nov; 68(22):9519-24. PubMed ID: 19010928
[TBL] [Abstract][Full Text] [Related]
13. MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo.
Hideshima T; Neri P; Tassone P; Yasui H; Ishitsuka K; Raje N; Chauhan D; Podar K; Mitsiades C; Dang L; Munshi N; Richardson P; Schenkein D; Anderson KC
Clin Cancer Res; 2006 Oct; 12(19):5887-94. PubMed ID: 17020997
[TBL] [Abstract][Full Text] [Related]
14. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis.
Pandey MK; Sung B; Kunnumakkara AB; Sethi G; Chaturvedi MM; Aggarwal BB
Cancer Res; 2008 Jul; 68(13):5370-9. PubMed ID: 18593939
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase Cdelta activates RelA/p65 and nuclear factor-kappaB signaling in response to tumor necrosis factor-alpha.
Lu ZG; Liu H; Yamaguchi T; Miki Y; Yoshida K
Cancer Res; 2009 Jul; 69(14):5927-35. PubMed ID: 19549902
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
